Clinical Trial 40312

share

Waltham, MA 02451


Study Summary:

This trial is comparing HF10®, a medical-device-based therapy, in combination with conventional medicine,* to conventional medicine alone in people who have painful diabetic neuropathy (also known as diabetic nerve pain). Eligible participants will receive investigational treatment at no cost and may receive compensation for time and travel.


*Conventional medical treatment includes the use of medication, physical therapy, cognitive therapy, chiropractic care, nerve blocks, and other noninvasive or minimally invasive therapies.



Qualified Participants Must:
  • Have diabetes
  • Experience painful nerve (neuropathic) pain in their feet and/or legs
  • Have experienced neuropathy pain for more than 12 months
  • Have taken gabapentin (eg, Neurontin® or Gralise®) or pregabalin (eg, Lyrica®)?


Qualified Participants May Receive:
Study-related treatment at no cost and may receive compensation for time and travel.


Study is Available At:

To learn more visit the study website.

To view an updated list of participating research sites click here.

 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.